Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

(MNB) Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

When is the product expected to launch commercially in the UK and what are the pricing and reimbursement expectations? What market share can Mainz Biomed capture in the UK colorectal screening market versus existing competitors? How will UK registration of ColoAlert affect MNB's revenue forecast and earnings guidance?
Symbol: MNB
Regulation
13 days ago
Read more globenewswire

BUYOUT INVESTIGATION NOTICE: Kaskela Law LLC Announces Investigation of Soho House & Co Inc. (NYSE: SHCO) Stockholder Buyout and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options

(NYSE:SHCO) PHILADELPHIA, Sept. 2, 2025 /PRNewswire/ -- Investor counsel Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Soho House & Co...

How might the investigation and associated uncertainty affect SHCO’s short‑term liquidity and trading volume, and what risk does this pose for positions held at the time of the news? What are the possible outcomes of the Kaskela Law investigation—could it lead to a revised offer, legal delays, or the cancellation of the buyout? Is the proposed buyout price materially above the current market valuation, indicating a potential premium for shareholders?
Symbol: SHCO
Mergers
13 days ago
Read more prnewswire

Agilent’s MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

(NYSE:A) SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certif...

How does Agilent’s certification timeline and product positioning compare to other diagnostic companies offering MMR testing in Europe, and what are the implications for reimbursement and pricing? What impact will this companion diagnostic have on the market share and sales dynamics of Opdivo¼/Yervoy¼ combination therapy versus competing immunotherapies? How will the IVDR certification of Agilent’s MMR IHC Panel affect Agilent’s revenue forecasts and earnings guidance?
Symbol: A
Regulation
13 days ago
Read more businesswire